SH3P7 was originally isolated by cloning SH3 domain ligand targets from a mouse embryo cDNA library. SH3P7 is an actinbinding protein implicated in antigen reception, JNK1 signalling, and Rac activation. It contains a drebrin homology sequence in its N-terminal region and a cortactin homology sequence (SH3 domain) in its C-terminal region. Both drebrin and cortactin are actin-binding proteins, and both have been suggested as possible regulators of the actin cytoskeleton in neurons. In the present study, we performed cDNA cloning of rat SH3P7, performed RT-PCR analysis, generated polyclonal antibodies against the recombinant rat SH3P7 protein, and examined the distribution of SH3P7 in the rat brain using immunohistochemistry. Sequence analysis revealed that there were at least four isoforms of the SH3P7 protein: SH3P7r1±SH3P7r4. RT-PCR analysis revealed that the predominant isoforms expressed in the brain were SH3P7r1 and SH3P7r3. The relative levels of isoform expression were similar among regions. Immunohistochemistry revealed that the most intense immunolabelling for SH3P7 was observed in the hippocampus and cerebellar cortex. Double-labelling studies with anti-SH3P7 antibody and other neuronal marker proteins revealed that SH3P7 was located primarily in dendrites, and in moderate amounts in cell bodies. Immunoreactivity was absent in the presynaptic terminals. In cultured astrocytes, SH3P7 was localized at protrusive structures of the cell periphery and in the cell body. We concluded that SH3P7 is ubiquitous in the rat brain, and occurs as several isoforms. Also, its dendritic localization suggests that SH3P7 is functionally linked to actin cytoskeleton organization in dendrites.
Introduction
Dendritic spines are the specialized structures on which the majority of excitatory glutamatergic synapses in the brain have been found. Evidence accumulated over the past two decades has generated speculation that dendritic spines undergo rapid shape change in response to various stimuli. Recently, this speculation has been proved to be true by researchers using green¯uorescent protein (GFP)-tagged actin molecules (for review, see Matus, 2000) . However, the molecular basis of this rapid change is still unknown. Because such rapid morphological change may result from rearrangements of the actin cytoskeleton, the actin-binding proteins in dendritic spines are now a focus of interest in studies of synaptic function (Shirao & Sekino, 2001) .
We have recently shown that accumulation of an actin-binding protein, drebrin, within a dendritic spine results in elongation of the spine, possibly via rearrangements of the actin cytoskeleton (Hayashi & Shirao, 1999) . In the adult cerebral cortex, drebrin is concentrated primarily in the dendritic spines (Shirao et al., 1987; Shirao, 1995; Hayashi et al., 1996) . Biochemical studies have indicated that drebrin is a regulator of the actin cytoskeleton (Shirao et al., 1992 Ishikawa et al., 1994; Hayashi et al., 1996) . Drebrin contains an actin-depolymerizing factor homology (ADF-H) domain in its Nterminal region (Lappalainen et al., 1998) .
It has recently been reported that the N-terminal half of mouse SH3P7 is very similar to the N-terminal half of drebrin (Sparks et al., 1996) . SH3P7 has been identi®ed as a SH3 domain-containing protein. The SH3 domain is a well-characterized protein module that binds short proline-rich regions in target proteins (Yu et al., 1994) . SH3P7 binds to actin-®lament and is localized in cellular growth sites (Kessels et al., 2000) .
The SH3 domain of SH3P7 is similar to that of the actin-binding protein cortactin (Wu & Parsons, 1993) . The SH3 domain of cortactin binds with Shank proteins (CortBP1/Shank2 and Shank3), a family of postsynaptic scaffold proteins in dendritic spines (Du et al., 1998; Boeckers et al., 1999; Naisbitt et al., 1999; Sheng & Kim, 2000) . It has been suggested that a regulated Shank±cortactin interaction may be a mechanism for linking NMDA receptor activation to control of the postsynaptic actin cytoskeleton (Naisbitt et al., 1999) .
The similarities between SH3P7 and both drebrin and cortactin, which are actin-binding proteins in dendritic spines, raise the possibility that SH3P7 plays a role in the dendritic spine. Although it has been reported that SH3P7 is expressed in the brain (Larbolette et al., 1999) , we are not aware of any other studies of SH3P7 in neurons or glia. Therefore, in the present study, our intent was to characterize SH3P7 in detail in the rat brain. We ®rst cloned rat SH3P7 cDNAs from a rat hippocampus cDNA library, and then performed reverse transcription-polymerase chain reaction (RT-PCR) in order to analyse expression of SH3P7 mRNA. A fusion protein was constructed to generate polyclonal antibodies reactive with rat SH3P7. These antibodies speci®cally recognized SH3P7 protein in the rat brain, and were used to determine the distribution of rat SH3P7 with immunoblot analysis and immunohistochemistry.
Materials and methods
All experiments were carried out in accordance with guidelines of the Animal Care and Experimentation Committee, Gunma University, Showa Campus (Maebashi, Japan).
RNA isolation
The animals were deeply anesthetized with ether and killed by decapitation. Total RNA was isolated from a 7-week-old male Wistar rat brain, according to the methods of Chomczynski & Sacchi (1987) , using guanidinium thiocyanate. The RNA was then used for RT-PCR and Northern blotting.
Cloning of rat SH3P7 cDNA
First-strand cDNA was synthesized from 3 mg of total RNA. Immediately before the reaction, RNA was denatured at 75°C for 5 min in the presence of the reverse primer. The reaction mixture (20 mL) contained RNA, a deoxynucleotide triphosphate mixture, dithiothreitol, RNase inhibitor, and reverse transcriptase (Superscript II, Gibco BRL, Gaithersburg, MD, USA). The reaction was carried out at 42°C for 50 min. RT-cDNA was used as the template for PCR. The oligonucleotides used for PCR ampli®cation were as follows:
The PCR protocol consisted of 1 min of denaturation at 95°C, 2 min of annealing at 50°C, and 2 min of extension at 72°C, repeating the annealing and extension steps for 30 cycles. PCR products were subcloned into pBluescript IIsk + at XhoI/BamHI sites and then sequenced.
A rat hippocampus lgt10 cDNA library (» 6 Q 10 5 clones; a generous gift from Dr Nobuhiko Kojima of Laboratory for Neurobiology of Emotion, Brain Science Institute of RIKEN, Japan) was screened using a 243-bp cDNA probe that was PCRampli®ed from the above RT-PCR products using the primers 5¢-AGGGTGAAGGACCCCAACTCTG-3¢ (forward) and 5¢-GCAG-CTGCTTTCCTTATGGAAG-3¢ (reverse). The probe was labelled with digoxigenin (PCR DIG Probe Synthesis Kit, Boehringer Mannheim, Indianapolis, IN, USA) and hybridized to phages transferred to nylon membranes (Hybond-N + , Amersham, Little Chalfont, UK). Hybridization was performed in Rapid-hyb buffer (Amersham) with the PCR DIG probe (243 bp, 10 ng/mL) at 65°C for 3 h.
The membranes were washed in 2 Q saline sodium citrate (SSC) containing 0.1% (w/v) sodium dodecyl sulphate (SDS) at room temperature for 20 min, and twice in 0.1 Q SSC containing 0.1% SDS at 65°C for 15 min. The signals were detected immunologically using antidigoxigenin antibody conjugated to alkaline phosphatase and substrate (CSPD; Boehringer Mannheim). DNA fragments were subcloned into pBluescript IIsk + at NotI sites.
DNA sequencing
DNA sequences were determined with an automated DNA sequencer (ABI373A, Perkin-Elmer Japan, Urayasu, Japan), using the dyeterminator method. For the PCR reaction, a kit from Perkin-Elmer (Dye Terminator Cycle Sequencing Ready Reaction, Perkin-Elmer, Foster City, CA, USA) was used.
RT-PCR analysis
The expression pattern of the rat SH3P7 mRNA was determined by RT-PCR. cDNA transcription was performed using the procedure described earlier, but an oligo (dT) primer was used in the ®rst-strand synthesis reaction. The primer pairs (Pr0) used for PCR ampli®cation were as follows: 5¢-AACGCTACCAGGAACAGCACAG-3¢ (forward) and 5¢-GCTTGAAAATCTCCCGTGGGTG-3¢ (reverse). The PCR protocol consisted of 30 s of denaturation at 95°C, 30 s of annealing at 60°C, and 1 min of extension at 72°C, repeating the annealing and extension steps for 25 cycles. PCR products were visualized on a 15% (w/v) polyacrylamide gel containing 8 M urea.
Each speci®c primer pair (for SH3P7r1, SH3P7r2 and SH3P7r4) was designed according to the sequence data described in Table 1 ; the Pr3 primer pair recognized SH3P7r3 and SH3P7r4. Speci®c primers for SH3P7r3 could not be designed, due to the similarity between SH3P7r3 and SH3P7r4. The PCR protocol consisted of 30 s of denaturation at 95°C, 30 s of annealing at 68°C, and 30 s of extension at 72°C, repeating the annealing and extension steps for 25 cycles. PCR products were visualized on a 2.0% (w/v) agarose gel.
Northern blot analysis
Total RNA samples (30 mg per lane) were electrophoresed on 1% agarose gel containing formaldehyde, and transferred by capillary action onto a nylon membrane (Hybond-N + , Amersham). Hybridization and detection were performed using the procedures described earlier.
Production of polyclonal antibodies against rat SH3P7
Full-length rat SH3P7 cDNA (SH3P7r1) was subcloned into the His 6 -tagged fusion vector pET19b (Novagen, Madison, WI, USA) at its BamHI site, using PCR with high-®delity Pfu DNA polymerase (Stratagene, La Jolla, CA, USA). Bacterially expressed His 6 -tagged SH3P7 protein was af®nity-puri®ed using a Ni 2+ column (HiTrap Chelating, Amersham Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's instructions. This His 6 -tagged rat SH3P7 protein (2 mg) was used to immunize rabbits. To isolate rat SH3P7-speci®c antibodies, the crude antiserum was incubated for 3 h at 4°C with a rat SH3P7-af®nity column, which was prepared by covalently linking His glycine-HCl (pH 2.5), followed by immediate neutralization with 0.1 vol of 1 M Tris-HCl (pH 8.0). The eluate was dialysed against Tris-buffered saline using a desalting column (PD-10, Amersham Pharmacia Biotech). These anti-SH3P7 antibodies recognized all isoforms (GFP-SH3P7r1-r4).
Cell culture and transfection
To construct a GFP-fusion protein, a rat SH3P7r1±SH3P7r4 cDNA fragment was subcloned into an enhanced green¯uorescent protein-C1 vector (pEGFP-C1; Clontech, Palo Alto, CA, USA) at XhoI/ BamHI sites. COS-7 monkey kidney epithelial cells were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal bovine serum, at 37°C in a 5% CO 2 atmosphere. Cells were grown on glass coverslips and transfected using the CaPO 4 method. Thē uorescence of GFP-fusion protein was detected using an FITC (¯uorescein isothiocyanate) ®lter set.
Immunoblot analysis
The transfected COS-7 cells were grown in 35-mm culture dishes and then solubilized with sodium dodecyl sulphate (SDS) buffer (200 mL), and 1/40th of the extract was loaded into each lane. For analyses of other tissues, Wistar rats were killed by decapitation after being deeply anesthetized by ether, and various tissues were dissected and homogenized using a Te¯on homogenizer. The amounts of protein were normalized to the wet weights of the original tissue samples.
For immunoblot analysis, the samples were denatured and subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were then transferred onto an Immobilon Transfer Membrane (Millipore, Bedford, MA, USA) and processed for immunodetection. After transfer, the membranes were blocked in 10% nonfat milk/phosphate-buffered saline (PBS). The membranes were incubated for 12±16 h at 4°C in 3% bovine serum albumin (BSA)/PBS with either rabbit polyclonal antibodies against SH3P7 or a rat monoclonal anti-GFP antibody (generously donated by Dr Shinobu Fujita, Mitsubishi Kagaku Lifescience Institute, Japan). The membranes were washed three times for 20 min each time in PBS, and incubated for 1 h at room temperature with the peroxidaseconjugated secondary antibody (Cappel, West Chester, PA, USA). The membranes were then washed three times for 20 min each time in PBS, and the bands were visualized using enhanced chemiluminescence (Amersham).
Immunohistochemistry
Pentobarbital-anaesthetized, 7-week-old, male Wistar rats were perfused intracardially with a ®xative of 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brain tissue was then post®xed in this same ®xative for 12 h, and then equilibrated with 30% sucrose in PBS at 4°C. Frozen sections, 12±14 mm thick, were cut on a cryostat and mounted on poly L-lysine-subbed glass slides. Sections were treated with 0.1% Triton X-100 in PBS for 10 min, and incubated with 3% BSA/PBS for 1 h. They were then incubated with the primary antibody for 12 h at 4°C, washed with PBS four times for 5 min each time, incubated with the biotinylated secondary antibody (Vector Laboratories, Burlingame, CA, USA) for 1 h at room temperature, and washed four times for 5 min each time. Visualization was performed with 3,3¢-diaminobenzidine, using the ABC method (Vectastain Elite kit, Vector Laboratories).
For double-immunostaining, sections were incubated with a mixture of rabbit polyclonal antibody against SH3P7 and a monoclonal antibody against drebrin, synaptophysin, MAP2 (microtubuleassociated protein 2), or GFAP (glial ®brillary acidic protein). Monoclonal antibodies against drebrin (M2F6, and synaptophysin (171B5, Obata et al., 1986) were obtained from the culture supernatants of hybridoma cells that secreted them. Monoclonal antibodies against MAP2 (Sigma, St Louis, MO, USA) and GFAP (Boehringer Mannheim) were purchased from the sources indicated. A mixture of an FITC-conjugated antibody against rabbit IgG (Cappel) and a Texas red-conjugated antibody against mouse IgG (EY laboratories, San Mateo, CA, USA) was used for visualization. Sections were examined using a confocal laser microscope (MRC-1024, Bio-Rad, Hertfordshire, UK).
Primary culture of hippocampal neurons were prepared from 18-day rat embryos, according to a method described elsewhere (Banker & Cowan, 1977; Goslin et al., 1998) . After seeding, neurons were cultured on poly L-lysine-coated coverslips for 21 days in minimum essential medium with 10% horse serum at a density of » 3000 cells per cm 2 . Astrocytes were cultured for 7 days by using the same procedures. After ®xation with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), the cells were washed in PBS and treated with 0.1% Triton X-100 in PBS for 10 min, and then incubated with 3% BSA in PBS for 1 h. The cells were incubated with a mixture of rabbit polyclonal antibody against SH3P7 and a monoclonal antibody against drebrin, synaptophysin or GFAP. Visualization was performed using the procedures indicated earlier.
Electron microscopy
For immunoelectron microscopy, 7-week-old, pentobarbital-anaesthetized male Wistar rats were perfused intracardially using 4% paraformaldehyde with 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). The brain tissue was cut into small pieces, and immersed in the same ®xative for an additional 8 h in 0.1 M phosphate buffer (pH 7.4) containing 7% sucrose. The brain tissue pieces were infused with a mixture of polyvinylpyrrolidone and 2.3 M sucrose, and frozen rapidly in liquid nitrogen (Tokuyasu, 1986) . Semithin and ultrathin cryosections were cut with a Reichert Ultracut S equipped with the cryosectioning system FCS. Ultrathin cryosections on formvar-coated copper grids were subjected to immunogold labelling for electron microscopy. The af®nity-puri®ed rabbit anti-SH3P7 antibody or the monoclonal antibody against synaptophysin were applied, followed by 10 nm colloidal goldconjugated goat antirabbit IgG (Amersham). To con®rm the speci®city of the reaction, we used preabsorbed anti-SH3P7 antibody with His 6 -tagged rat SH3P7 fusion protein. The sections were adsorptionstained with neutral uranyl acetate (Tokuyasu, 1980) and embedded in a mixture of 2% methylcellulose (Nacalai Tesque, Kyoto, Japan) and 0.4% uranyl acetate (Grif®ths et al., 1984) . They were examined under a JEOL 100C Q electron microscope operated at 80 kV.
Results

Molecular cloning of four isoforms of rat SH3P7 cDNA
To amplify fragments of the rat SH3P7 sequences for use in probing cDNA libraries, RT-PCR was performed using degenerate primers based on the known sequence of mouse SH3P7. Using rat brain RTcDNA as the template, fragments which matched the predicted molecular weight were ampli®ed and then subcloned. Sequence analysis of these cloned fragments con®rmed that they represented the rat homologues of the known mouse SH3P7 sequence. These partial sequences were subsequently used as probes to screen the rat hippocampus cDNA library.
Screening of » 6 Q 10 5 phage clones resulted in the isolation of 16 independent clones. DNA sequence analysis of these clones revealed that there were four different isoforms of rat SH3P7. Four different amino acid sequences were found in the middle portion of the sequences of these SH3P7 isoforms. These sequences were PPSPSSRTÐWES, PPSRTÐWES, PPRTÐWES, and PPRTÐWS (Fig. 1A) . The symbol`Ð' represents the amino acid sequence GELEQEVVSRSRQE. These isoforms will be referred to as SH3P7r1, SH3P7r2, SH3P7r3 and SH3P7r4. The calculated molecular weights of SH3P7r1, SH3P7r2, SH3P7r3 and SH3P7r4 were about 48.6, 48.3, 48.2 and 48.1 kDa, respectively. The SH3P7r4 isoform had a shorter noncoding region at the 3¢ end than the other isoforms (Fig. 1B) . Northern blot analysis revealed two SH3P7 mRNAs (Fig. 1C) . This is consistent with the previous report that described two SH3P7 mRNAs in mouse (Kessels et al., 2000) .
The rat SH3P7r1 sequence differed from the mouse SH3P7 sequence by three gaps and 23 amino acid differences in the middle region (Fig. 2) . In contrast, the ADF-H domain sequences in the Nterminal region and the SH3 domain sequences in the C-terminal region were identical (Fig. 2, boxes) . Figure 3 shows the nucleotide sequences of the variable region (Fig. 2, underlined) . These sequences contained the highly conserved AG nucleotides in the deletion sites (Fig. 3, shaded) . The nucleotide sequences of rat SH3P7 cDNAs were deposited in the DDBJ/EMBL/ GenBank DNA databases under the accession numbers AB038365(SH3P7r1), AB039818(SH3P7r2), AB039819(SH3P7r3) and AB038364(SH3P7r4).
Expression patterns of four isoforms of rat SH3P7 mRNA
The results of molecular cloning of rat SH3P7 revealed that it exists in at least four isoforms. The expression pattern of each type of rat SH3P7 mRNA was analysed by RT-PCR, using Pr0 primer pairs (Table 1) The 3¢ terminal sequence of the SH3P7r4 cDNA is shorter than that of the cDNAs of the other rat SH3P7 isoforms. (C) Northern blot analysis revealed two bands of rat SH3P7 mRNAs. Thirty micrograms of total brain RNA was loaded. The blot was hybridized with a PCR DIG probe (489-bp corresponding to amino acids 275±436 of SH3P7r1), which is a sequence common to SH3P7r1, SH3P7r2, SH3P7r3 and SH3P7r4. cerebral cortex, cerebellum, hippocampus, olfactory bulb, brain stem and spinal cord (Fig. 4A) . As shown in Fig. 4A , SH3P7r1 mRNA was expressed in all areas examined. However, the expression patterns of SH3P7r2, SH3P7r3 and SH3P7r4 could not be determined clearly, because the stained bands obtained were indistinct due to the small differences in nucleotide length among the PCR products for these isoforms. To gain a clearer understanding of the expression of the isoforms, we examined expression using the oligonucleotide primers Pr1, Pr2, Pr3 and Pr4 (Table 1) . The primers Pr1, Pr2 and Pr4 are speci®c for SH3P7r1, SH3P7r2 and SH3P7r4, respectively, and the primer Pr3 recognizes both SH3P7r3 and SH3P7r4. RT-PCR analysis with these primers revealed that SH3P7r1 and SH3P7r3 are expressed in the greatest quantities in the cerebral cortex (Fig. 4B) . Although Pr3 recognizes two isoforms, the band ampli®ed by this primer re¯ects the amount of SH3P7r3 mRNA, because the ampli®cation of the SH3P7r4 fragment from the cerebral cortex was found to yield a small amount of product. Expression of SH3P7r2 was found to be low in comparison with SH3P7r1 and SH3P7r3. The relative levels of isoform expression (as revealed by RT-PCR ampli®cation) observed in the cerebral cortex were similar to those observed in the FIG. 2. Amino acid sequence comparison between rat SH3P7 (SH3P7r1) and mouse SH3P7 (mSH3P7). These sequences were aligned by GENETYX software. Identical amino acids are marked by asterisks (*). Gaps (Ð) are inserted to align amino acids. The underlined sequence denotes the variable region (amino acids 243±257 of SH3P7r1). The ADF-H domain (amino acids 7±133 of SH3P7r1) and the SH3 domain (amino acids 380±436 of SH3P7r1) are indicated by boxes. The amino acid sequence of mouse SH3P7 is taken from Sparks et al. (1996) (GenBank accession number U58884).
FIG. 3.
The nucleotide sequences of the variable region of SH3P7r1±SH3P7r4 isoforms. The conserved AG nucleotides are shaded. It is predicted that these dinucleotides are 3¢ splicing sites (acceptor sites) of introns. The gaps in the alignment are denoted by (±). cerebellum, hippocampus, olfactory bulb, brain stem and spinal cord (data not shown).
Immunoblot analysis of rat SH3P7
Rabbit polyclonal antibodies were generated against the full-length His 6 -SH3P7r1 fusion protein expressed in bacteria, and were af®nity puri®ed. These antibodies were used for immunoblot analysis of various rat tissues and immunohistochemistry. To characterize these antibodies, Western blot analysis was performed on the lysates from COS-7 cells expressing GFP-SH3P7r1 or GFP. The anti-GFP antibody recognized GFP-SH3P7r1 at » 90 kDa and GFP at » 32 kDa, following SDS-PAGE (Fig. 5A, left) . The anti-SH3P7 antibodies immunostained the 90-kDa band but not the 32-kDa band (Fig. 5A, right) . This demonstrated that the anti-SH3P7 antibodies recognized the rat SH3P7 protein. Two faint bands in Fig. 5A (anti-SH3P7, indicated by arrowhead) appear to represent endogenous SH3P7-like immunoreactivity in COS-7 cells, because they were observed for all lysates.
Using these antibodies, the distribution of SH3P7 was analysed in various rat tissues. The anti-SH3P7 antibodies immunostained bands at 55 kDa and 57 kDa (very close together on the SDS-PAGE) in lysates of tissue from cerebral cortex, cerebellum, hippocampus, olfactory bulb, brain stem and spinal cord (Fig. 5B) . In several brain regions, both 55-kDa and 57-kDa bands were detected in approximately equal amounts. In lysates of liver tissue, the staining intensity of the 57-kDa band was weaker than that of the 55-kDa band. Only very low expression of SH3P7 was detected in skeletal muscle. The 55-kDa and 57-kDa bands were also detected using other anti-SH3P7 antibodies, which were produced by immunizing a rabbit with a keyhole limpet hemocyanin (KLH) -coupled peptide corresponding to amino acids 210±232 (RERELQEAARREQRYQEQHRSAG) of the SH3P7r1 protein (data not shown).
Immunohistochemical localization of SH3P7 in rat brain
The distribution of SH3P7 in rat brain coronal sections was examined immunohistochemically. SH3P7-like immunoreactivity (IR) was observed in most areas of the brain, but expression levels differed among regions (Fig. 6A) , with the highest expression observed in the hippocampus and in the molecular layer of the cerebellar cortex. Moderate staining was observed in the molecular layer of the cerebral cortex, thalamus and amygdaloid nuclear complex. This staining Note that anti-SH3P7 antibodies recognized GFP-SH3P7, but not GFP. The two faint bands indicated by arrowheads represent endogenous SH3P7-like immunoreactivity in COS-7 cells. (B) Extracts from various tissues were electrophoresed on a 10% polyacrylamide gel. A total of 50 mg (wet weight) of each original tissue sample was loaded into each lane. The membrane was immunostained with anti-SH3P7 antibodies. cx, cerebral cortex; cb, cerebellum; hp, hippocampus; ob, olfactory bulb; bs, brain stem; sc, spinal cord; lv, liver; sm, skeletal muscle. pattern was speci®cally abolished by preabsorption of anti-SH3P7 antibody with the immunogen fusion protein.
In the hippocampus, strong immunoreactivity was detected in the stratum radiatum, stratum oriens and the molecular layer of the dentate gyrus (Fig. 6B) . In the CA1 area, dot-like staining and dendrite-shaped staining patterns were observed ( Fig. 6C and E) . In contrast, only low levels of immunoreactivity were observed in cell layers. In the molecular layer of the cerebellum, punctate staining was consistently observed in addition to the staining of Purkinje cell somata (Fig. 6F) . Weak staining was observed in the granular layer (Fig. 6D) .
SH3P7 is located primarily in dendrites
To investigate the cellular localization of SH3P7, we employed double immuno¯uorescence staining and confocal laser microscopy. Antibodies against MAP2 (speci®c for neurons, especially dendritic processes), GFAP (speci®c for astrocytes), drebrin (antibody M2F6, speci®c for dendritic spines), and synaptophysin (antibody 171B5, FIG. 6 . Distribution of SH3P7-like immunoreactivity in coronal section of rat brain. (A) SH3P7 immunoreactivity was widely distributed throughout the brain. cx, cerebral cortex; hp, hippocampus; th, thalamus; am, amygdaloid nuclear complex. Scale bar, 3 mm. (B) Hippocampal formation. CA1 and CA3, ®elds of the hippocampus; DG, dentate gyrus; so, stratum oriens; py, pyramidal cell layer; sr, stratum radiatum; sl, stratum lacunosum-moleculare of the hippocampus; mo, molecular layer of the dentate gyrus. Scale bar, 400 mm. . In C, it can be seen that SH3P7 is localized in neurons, especially dendrites. The stratum radiatum of the CA1 area was double-immunostained with antibodies against SH3P7 (D, green) and GFAP (E, red). SH3P7 partially colocalized with GFAP immunoreactivity (F). Cultured astrocytes were double-immunostained with antibodies against SH3P7 (G, green) and GFAP (H, red). SH3P7 was localized in the cell body and protrusive structures (arrowheads, G) of the cell periphery, which did not stain for GFAP (I). Scale bars, 10 mm.
speci®c for presynaptic terminals) were used together with the anti-SH3P7 antibodies. Double-immunolabelling of the hippocampal CA1 area for SH3P7 (green) and MAP2 (red) revealed SH3P7-IR in neurons, primarily in dendrites and, to a small degree, in cell somata (Fig. 7A±C) . Doubleimmunolabelling of the hippocampal CA1 area for SH3P7 (green) and GFAP (red) resulted in a small number of punctate stainings for SH3P7 in astrocytes (Fig. 7D±F ), but it was not clear whether the staining was associated with astrocytes or with neuronal structures. In order to determine whether SH3P7 was expressed in astrocytes, we employed primary-cultured brain cells for immuno¯uorescence staining. Figure 7I shows SH3P7-IR in a GFAP-positive astrocyte, in which it was observed to be localized strongly in cell protrusions, in addition to the cell soma (Fig. 7G±I) . Double-immunolabelling of the hippocampal CA1 area for SH3P7 (green) and drebrin (red) revealed colocalization of these two antigens in dendritic spines in the hippocampal CA1 area (Fig. 8A±  D) . The predominantly postsynaptic localization of SH3P7 protein in the hippocampal CA1 area was indicated by the absence of SH3P7-IR (green) in the synaptophysin-positive presynaptic terminals (red; Fig. 8E±H ). To determine the subcellular distribution of SH3P7 in neurons, hippocampal neuronal cultures (3 weeks in vitro) were double-labelled with the antibody against SH3P7 and drebrin or synaptophysin. SH3P7-IR showed a dendritic localization that overlapped with drebrin labelling at dendritic spines (Fig. 8I±K) . The synaptophysin-positive presynaptic terminals were closely adjacent to the SH3P7-IR (Fig. 8L±N) .
To further substantiate the dendritic localization of SH3P7, we employed a postembedding immunoelectron microscopy method. Immunogold labelling for SH3P7 in the stratum radiatum within the CA1 region of the hippocampus was located predominantly in the postsynaptic site (Fig. 9A) . In contrast, presynaptic terminals were almost devoid of SH3P7-IR. As expected, synaptophysin-positive gold particles were observed at the presynaptic site (Fig. 9C) . Preabsorption of the antibody with the His 6 -tagged rat SH3P7 fusion protein used as immunogen abolished the SH3P7-IR in postsynaptic site (Fig. 9B) . These results were consistent with the light microscopy and double-immunolabelling ®ndings.
Discussion
In this study, we demonstrated that SH3P7 is expressed ubiquitously in the brain and that, within neurons, it is located primarily in dendrites. Molecular cloning of SH3P7 cDNA from a rat hippocampus cDNA library revealed the existence of at least four isoforms of rat SH3P7 (SH3P7r1±SH3P7r4). Analysis of SH3P7 mRNAs using RT-PCR revealed that the relative expression levels of the isoforms are similar in the different brain regions and that the subtypes of SH3P7 expressed in the greatest quantities in the brain are SH3P7r1 and SH3P7r3.
Rat SH3P7 has at least four isoforms, SH3P7r1±SH3P7r4 (Fig. 1A) . The following observations indicate that they are produced by alternative splicing mechanisms from a single gene. First, the nucleotide sequences of these isoforms are identical not only in their coding region but also in their noncoding regions except for the variable region (data not shown, DDBJ/EMBL/GenBank accession numbers AB038365, AB039818, AB039819and AB038364). Second, SH3P7r1±SH3P7r3 contain the dinucleotide AG at consensus positions (Fig. 3) . It is known that the dinucleotide AG is conserved at 3¢ splicing sites (acceptor sites) of introns (Lewin, 2000) .
Sequence analysis indicated that ADF-H and SH3 domains are highly conserved in rat and mouse SH3P7. Mouse SH3P7 corresponds to SH3P7r2 of the rat. In a previous study, a mouse SH3P7 splicing variant molecule, in which serine 235 was absent, was reported (Kessels et al., 2000) . This splicing variant of mouse SH3P7 corresponds to rat SH3P7r3. Among the four isoforms of rat SH3P7 identi®ed in the present study, only SH3P7r1 contains the sequence serine-proline-serine-serine (SPSS) at amino acid positions 235±238. The SPSS sequence is a subset of a unique amino acid sequence (PPSPSS, Fig. 1A ), which contains a putative SH3 domain-binding motif, the consensus PXXP. Thus, SH3P7r1 contains an SH3 domainbinding motif in its variable region, in addition to other PXXP consensus sequences at amino acid positions 309 and 326. Although the physiological role of this sequence (PPSPSS) has yet to be investigated, one possibility is that there are intramolecular interactions within SH3P7r1 molecules between PPSPSS sequences and SH3 domains. Another possibility is that this sequence plays a role in intermolecular interactions with other proteins. However, when fusion proteins consisting of EGFP and the isoforms of rat SH3P7 (SH3P7r1±SH3P7r4) were introduced into Chinese hamster ovary cells, no great differences were observed in localization among the fusion proteins formed from the different SH3P7 isoforms (data not shown).
Immunoblot and RT-PCR analyses demonstrated that SH3P7 was expressed ubiquitously in rat brains and that the relative levels of expression of the different isoforms were similar across the different brain regions. Immunohistochemistry revealed that apparent intense immunoreactivity was observed in the hippocampus and cerebellum, where dendrite-like processes in the neuropil showed distinct staining. Confocal microscopic examination of tissues doubleimmunolabelled for SH3P7 and MAP2 revealed that SH3P7 is localized in neurons, and especially in their dendrites. The punctate staining patterns observed in the hippocampus and cerebellum suggest that SH3P7 is localized at synapses. Also, SH3P7 is colocalized partially with drebrin in dendritic spines, but not with synaptophysin in presynaptic terminals, indicating that SH3P7 is localized in dendritic spines. The localization of SH3P7 of dendritic spines was also con®rmed by immunoelectron microscopy of hippocampal tissue and by double-immunostaining of cultured hippocampal neurons. Taken together, these two ®ndings indicate strongly that SH3P7 in neurons is localized mainly in dendritic shafts and to a lesser extent in dendritic spines. Our ®ndings also indicate that astrocytes express SH3P7 in vivo, although the expression level is low compared with that observed in neurons. In cultured astrocytes, SH3P7 accumulated at protrusive structures of the cell periphery. Such a pattern of SH3P7 localization is consistent with a previous report that SH3P7 colocalizes with cortical F-actin in ®broblast protrusions, which represent sites of actin-rich cellular growth (Kessels et al., 2000) .
The human homologue of SH3P7, HIP-55 (HPK1-interacting protein of 55 kDa), binds to haematopoietic progenitor kinase 1 (HPK1) in 293T cells, and regulates the c-Jun N-terminal kinase 1 (JNK1) signalling cascade (Ensenat et al., 1999) . In the brain, JNKs are expressed primarily in neurons (Xu et al., 1997) . JNKs are implicated in early brain development through mediation of neuronal apoptosis (Kyriakis & Avruch, 1996; Ip & Davis, 1998; Kuan et al., 1999) . Because SH3P7 is expressed in neurons, it might be involved in neuronal apoptosis, through regulation of the JNK signalling pathway during development.
SH3P7 is an actin-binding protein, and is a substrate for activated protein tyrosine kinases (Larbolette et al., 1999) . In lymphocytes, it has been suggested that SH3P7 acts as an adapter protein that functionally links antigen receptor signalling to components of the cytoskeleton (Larbolette et al., 1999) . Therefore, the presence of SH3P7 in dendritic spines raises the possibility that SH3P7 acts as an adapter protein that functionally links neurotransmitter receptor signalling to the actin cytoskeleton in dendritic spines and is involved in the regulation of actin cytoskeleton organization.
